Protagenic Therapeutics terminates CFO Alexander Arrow, effective April 30, 2026

Protagenic Therapeutics, Inc.new

CFO Alexander Arrow notified on March 31, 2026 that employment will be terminated.
Termination effective April 30, 2026; no successor or interim CFO announced.
Company common stock (PTIX) and warrants (PTIXW) trade on OTC Markets.

item 5.02

Source: SEC EDGAR

accession 0001493152-26-015365

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.